Wednesday, May 23, 2007

Leader to Leader Influence

Leadership is about relationships and influence, and leader to leader influence is the most powerful leadership strategy I know of.

Question: Is your economic development organization using its leaders to influence other leaders in key industries and clusters where your area hopes to compete? Hopefully so.

Is biotechnology/bioscience a target industry or cluster for your area? If so, your organization should be positioning itself with the leaders of this industry to build your reputation as an attractive place for bio-related development to occur.

And yes, the same leader to leader influence strategy can be used with any industry or technology area.

Here is a list of the people serving on the Biotechnology Industry Organization (BIO). How can you use your area leaders to make in-roads with these bio leaders? (And yes, there are others beyong the BIO Board.) Perhaps some of your local leaders serve on BIO's board of directors. Work on a leader to leader influence strategy to capitalize on opportunities in this important and exciting sector. One word to bear in mind as you craft your strategy: Diplomacy!

Biotechnology Industry Organization (BIO) Board of Directors

Vice Chair, Food & Agriculture and Secretary
Andrew Baum
President & CEO
SemBioSys Genetics, Inc.

Chair: Joshua Boger, Ph.D.
President & CEO
Vertex Pharmaceuticals Incorporated

Member
Catherine M. Bonuccelli, M.D.
Vice President, External Scientific Affairs
AstraZeneca, Inc.

Member
Robert B. Chess
Chairman
Nektar Therapeutics, Inc.

Member
Geoffrey F. Cox, Ph.D.
Chairman, President & CEO
GTC Biotherapeutics, Inc.

Member
Susan Desmond-Hellmann, M.D.
President, Product Development
Genentech, Inc.

Member
Douglas A. Doerfler
President & CEO
MaxCyte, Inc.

Member
Deborah Dunsire, M.D.
CEO
Millennium Pharmaceuticals

Member
Reiner Emrich
Executive Vice President
BASF Plant Science Holding, Inc.

Member
Elliot Entis
President & CEO
Aqua Bounty Technologies

Member
Fabrice Egros, Ph.D.
President & CEO
UCB, Inc.

Member
Dennis M. Fenton, Ph.D.
Executive Vice President
Amgen, Inc.

Member
Fereydoun Firouz
President
EMD Serono, Inc.

Member
Colin A. Goddard, Ph.D.
CEO
OSI Pharmaceuticals, Inc.

Member
Neal Gutterson
President & CEO
Mendel Biotechnology

Member
David F. Hale
Chairman
Micromet, Inc.

Member
Steven H. Holtzman
Chairman & CEO
Infinity Pharmaceuticals, Inc.

Member
Jeffrey Kindler
Chairman & CEO
Pfizer, Inc.

Member
Rachel K. King
CEO
GlycoMimetics, Inc.

Member
Thomas P. Koestler, Ph.D.
Executive Vice President
Schering Plough

Member
Louis G. Lange, M.D., Ph.D.
Chairman & CEO
CV Therapeutics, Inc.

Member
John M. Leonard, M.D.
Vice President, Global Medical & Scientific Affairs
Abbott Laboratories, Inc.

Member
Gregory T. Lucier
Chairman & CEO
Invitrogen Corporation

Member
John M. Maraganore, Ph.D.
President, Director & CEO
Alnylam Pharmaceuticals, Inc.

Member
Russell M. Medford, M.D., Ph.D.
President, CEO & Scientific Co-founder
AtheroGenics, Inc.

Member
Arlene M. Morris
President & CEO
Affymax, Inc.

Member
David M. Mott
Vice Chairman, President & CEO
MedImmune, Inc.

Immediate Past Chair
James C. Mullen
President & CEO
Biogen Idec, Inc.

Member
Thomas Nagy
President & CEO
Novozymes North America, Inc.

Member
Thomas B. Okarma, M.D., Ph.D.
President, Director & CEO
Geron Corporation

Member
H. Stewart Parker
President & CEO
Targeted Genetics Corporation

Member
Robert Parkinson
Chairman, President & CEO
Baxter International

Member
Steven M. Paul, M.D.
Executive Vice President, Science & Technology
Eli Lilly & Company

Member
Richard F. Pops
Chairman
Alkermes, Inc.

Member
David E. I. Pyott
Chairman & CEO
Allergan, Inc.

Member
Hollings C. Renton
Chairman, President & CEO
Onyx Pharmaceuticals, Inc.

Member
Robert R. Ruffolo Jr., Ph.D.
President, Research & Development
Wyeth Pharmaceuticals, Inc.

Member
Una S. Ryan, Ph.D.
President & CEO
AVANT Immunotherapeutics, Inc.

Member
Mitchel Sayare, Ph.D.
Chairman, President & CEO
ImmunoGen, Inc.

Member
Mark W. Schwartz, Ph.D.
President & CEO
Bayhill Therapeutics, Inc.

Vice Chair, Healthcare
Joseph C. Scodari
Worldwide Chairman, Pharmaceuticals Group
Johnson & Johnson

Member
Alan Shaw, Ph.D.
President & CEO
Codexis, Inc.

Member
Stephen A. Sherwin, M.D.
Chairman & CEOCell
Genesys, Inc.

Member
Feike Sijbesma
Member, Managing Board of Directors
DSM, NV

Treasurer
Mark Skaletsky
Chairman, President & CEO
Trine Pharmaceuticals, Inc.

Member
Martin Soeters
President
US Novo Nordisk

Member
Henri A. Termeer
Chairman, President & CEO
Genzyme Corporation

Member
Harold E. Van Wart, Ph.D.
President, Director & CEO
Metabolex, Inc.

Member
David J. Williams
Chairman
President & CEO
sanofi pasteur

Source: Biotechnology Industry Organization

No comments: